UPDATED
First wave of Humira biosimilars enters EU market
Novartis and Amgen have announced today that their biosimilars to Humira are available across the European market.
Archives for October 16, 2018
US FDA approves the manufacturing of rare lung disease treatment
Therapure was granted approval for the manufacture of Insmed Incorporated’s drug Arikayce at its Missassauga, Canada facility.
Lonza expands manufacturing sites for larger ADC payloads
Lonza Pharma & Biotech will expand two of its manufacturing sites to reach the capabilities necessary to produce compounds bio-conjugates through to commercialization.